Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective?
Saved in:
| Title: | Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective? |
|---|---|
| Authors: | Shaw BE; CIBMTR (Center for International Blood and Marrow Transplant Research)/Froedtert, Department of Medicine, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Suite C5500, Milwaukee, WI, 53226, USA. beshaw@mcw.edu. |
| Source: | Current hematologic malignancy reports [Curr Hematol Malig Rep] 2019 Feb; Vol. 14 (1), pp. 22-30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
